Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims

Clinical Therapeutics

Volumn 31, Issue 11, 2009, Pages 2584-2607

  McHorney, Colleen A ^a   Victor Spain, C ^a   Alexander, Charles M ^a   Simmons, Jeffrey ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

adherence; chronic disease; persistence with therapy; predictive validity

Indexed keywords

ANTIASTHMATIC AGENT; ANTILIPEMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; MINERAL; ORAL ANTIDIABETIC AGENT; VITAMIN;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG INDICATION; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; RISK ASSESSMENT; SAMPLE SIZE; SELF EVALUATION; SEX RATIO; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ALGORITHMS; CHRONIC DISEASE; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; FORECASTING; HEALTH SURVEYS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MASSACHUSETTS; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACIES; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SELECTION BIAS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 74549195212     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.11.030     Document Type: Article

References (131)

1. Haynes R.B., McDonald H.P., and Garg A.X. Helping patients follow prescribed treatment: Clinical applications. JAMA. 288 (2002) 2880-2883
2. DiMatteo M.R. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 42 (2004) 200-209
3. World Health Organization. Adherence to long-term therapies: Evidence for action. http://apps.who.int/medicinedocs/en/d/Js4883e/ Accessed March 15, 2007
4. Cramer J.A., Benedict A., Muszbek N., et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: A review. Int J Clin Pract. 62 (2008) 76-87
5. Bangsberg D.R., Perry S., Charlebois E.D., et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 15 (2001) 1181-1183
6. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care. 40 (2002) 794-811
7. Adachi J., Lynch N., Middelhoven H., et al. The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review. BMC Musculoskelet Disord. 8 (2007) 97
8. 1c) in patients with type 2 diabetes. Acta Diabetol. 44 (2007) 209-213
9. Breekveldt-Postma N.S., Penning-van Beest F.J., Siiskonen S.J., et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin. 24 (2008) 121-127
10. Jackevicius C.A., Li P., and Tu J.V. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 117 (2008) 1028-1036
11. Mahoney J.J. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 11 Suppl 5 (2005) S170-S176
12. Mahoney J.J. Value-based benefit design: Using a predictive modeling approach to improve compliance. J Manag Care Pharm. 14 Suppl B (2008) 3-8
13. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med. 13 (1983) 177-183
14. Weiden P., Rapkin B., Mott T., et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull. 20 (1994) 297-310
15. de Klerk E., van der Heijde D., van der Tempel H., and van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol. 26 (1999) 2635-2641
16. Svarstad B.L., Chewning B.A., Sleath B.L., and Claesson C. The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 37 (1999) 113-124
17. Kampman O., Lehtinen K., Lassila V., et al. Attitudes towards neuroleptic treatment: Reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire. Schizophr Res. 45 (2000) 223-234
18. Kennedy IV S.B. Developing a selfadministered tool to predict adherence to antiretroviral therapy: Design, method, and objectives. AIDS Patient Care STDS. 14 (2000) 309-316
19. Kim M.T., Hill M.N., Bone L.R., and Levine D.M. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 15 (2000) 90-96
20. Thompson K., Kulkarni J., and Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 42 (2000) 241-247
21. Willey C., Redding C., Stafford J., et al. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clin Ther. 22 (2000) 858-871
22. Girerd X., Hanon O., Anagnostopoulos K., et al. Assessment of antihypertensive compliance using a selfadministered questionnaire: Development and use in a hypertension clinic [in French]. Presse Med. 30 (2001) 1044-1048
23. Girerd X., Radauceanu A., Achard J.M., et al. Evaluation of patient compliance among hypertensive patients treated by specialists [in French]. Arch Mal Coeur Vaiss. 94 (2001) 839-842
24. Martin J., Escobar I., Rubio R., et al. Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV. HIV Clin Trials. 2 (2001) 31-37
25. Mathews W.C., Mar-Tang M., Ballard C., et al. Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care STDS. 16 (2002) 157-172
26. Schoberberger R., Janda M., Pescosta W., and Sonneck G. The COMpliance Praxis Survey (COMPASS): A multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens. 16 (2002) 779-787
27. Dolder C.R., Lacro J.P., Warren K.A., et al. Brief evaluation of medication influences and beliefs: Development and testing of a brief scale for medication adherence. J Clin Psychopharmacol. 24 (2004) 404-409
28. Walewski K.M., Cicutto L., D'Urzo A.D., et al. Evaluation of a questionnaire to assess compliance with antiasthma medications. J Asthma. 41 (2004) 77-83
29. George J., Mackinnon A., Kong D.C., and Stewart K. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns. 64 (2006) 50-60
30. Highstein G.R., Willey C., and Mundy L.M. Development of Stage of Readiness and decisional balance instruments: Tools to enhance clinical decisionmaking for adherence to antiretroviral therapy. AIDS Behav. 10 (2006) 563-573
31. Balfour L., Tasca G.A., Kowal J., et al. Development and validation of the HIV Medication Readiness Scale. Assessment. 14 (2007) 408-416
32. Walsh J.C., Mandalia S., and Gazzard B.G. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 16 (2002) 269-277
33. Hahn S.R., Park J., Skinner E.P., et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 24 (2008) 2127-2138
34. Pawin H., Beylot C., Chivot M., et al. Creation of a tool to assess adherence to treatments for acne. Dermatology. 218 (2008) 26-32
35. Zelikovsky N., and Schast A.P. Eliciting accurate reports of adherence in a clinical interview: Development of the Medical Adherence Measure. Pediatr Nurs. 34 (2008) 141-146
36. Zeller A., Schroeder K., and Peters T.J. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 61 (2008) 282-288
37. Jank S., Bertsche T., Schellberg D., et al. The A14-scale: Development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci. 31 (2009) 426-431
38. McHorney C.A. The Adherence Estimator: A brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 25 (2009) 215-238
39. Prado-Aguilar C.A., Martinez Y.V., Segovia-Bernal Y., et al. Performance of two questionnaires to measure treatment adherence in patients with type-2 diabetes. BMC Public Health. 9 (2009) 38
40. Matza L.S., Yu-Isenberg K.S., Coyne K.S., et al. Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population. Curr Med Res Opin. 24 (2008) 3197-3206
41. Koneru S., Shishov M., Ware A., et al. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum. 57 (2007) 1000-1006
42. Rathbun R.C., Farmer K.C., Lockhart S.M., and Stephens J.R. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection. Ann Pharmacother. 41 (2007) 208-214
43. Cramer J.A., Roy A., Burrell A., et al. Medication compliance and persistence: Terminology and definitions. Value Health 11 (2008) 44-47
44. Peterson A.M., Nau D.P., Cramer J.A., et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 10 (2007) 3-12
45. Andrade S.E., Kahler K.H., Frech F., and Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 15 (2006) 565-574
46. discussion. Andrade S.E., Kahler K.H., Frech F., and Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 15 (2006) 575-577
47. Martin B.C., Wiley-Exley E.K., Richards S., et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 43 (2009) 36-44
48. Bramley T.J., Gerbino P.P., Nightengale B.S., and Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 12 (2006) 239-245
49. Hess L.M., Raebel M.A., Conner D.A., and Malone D.C. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Ann Pharmacother. 40 (2006) 1280-1288
50. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). The National Drug Code Directory (2006), CDER, Washington, DC. http://www.fda.gov/cder/ndc Accessed April 10, 2008
51. Likert R. A technique for the measurement of attitudes. Arch Psychol. 140 (1932) 5-55
52. Ott L. An Introduction to Statistical Methods and Data Analysis. 4th ed. (1993), Duxbury Press, Pacific Grove, Calif
53. Somes G. The generalized Mantel-Haenszel statistic. Am Stat. 40 (1986) 106-108
54. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc. 57 (1995) 289-300
55. Rothman K.J., and Greenland S. Modern Epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, Pa
56. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
57. Hosmer Jr. D.W., and Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data (1999), Wiley, New York, NY
58. Hodges J., and Lehmann E. Estimates of location based on rank tests. Ann Math Stat. 34 (1963) 518-611
59. Raofi S., and Schappert S.M. Medication therapy in ambulatory care: United States, 2003-04. Vital Health Stat 13 (2006) 1-40
60. Martin L.R., Williams S.L., Haskard K.B., and Dimatteo M.R. The challenge of patient adherence. Ther Clin Risk Manag. 1 (2005) 189-199
61. Evans R.W., and Linde M. Expert opinion: Adherence to prophylactic migraine medication. Headache 49 (2009) 1054-1058
62. Williams L.K., Pladevall M., Xi H., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 114 (2004) 1288-1293
63. Davis K.L., Candrilli S.D., and Edin H.M. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia. 49 (2008) 446-454
64. Faught E., Duh M.S., Weiner J.R., et al. Nonadherence to antiepileptic drugs and increased mortality: Findings from the RANSOM Study. Neurology 71 (2008) 1572-1578
65. Faught R.E., Weiner J.R., Guérin A., et al. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study. Epilepsia. 50 (2009) 501-509
66. Lage M.J., and Hassan M.K. The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: A retrospective study. Ann Gen Psychiatry 8 (2009) 7
67. Sokol M.C., McGuigan K.A., Verbrugge R.R., and Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43 (2005) 521-530
68. Breekveldt-Postma N.S., Penning-van Beest F.J., Siiskonen S.J., et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin. 24 (2008) 1025-1031
69. Kane S., Huo D., Aikens J., and Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 114 (2003) 39-43
70. Caro J., Ishak K.J., Huybrechts K.F., et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 15 (2004) 1003-1008
71. 1c in type 2 diabetes. Ann Pharmacother. 38 (2004) 1357-1362
72. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 166 (2006) 1842-1847
73. Blouin J., Dragomir A., Moride Y., et al. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol. 66 (2008) 117-127
74. Goldman J.D., Cantrell R.A., Mulenga L.B., et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses 24 (2008) 1031-1035
75. Ho P.M., Magid D.J., Shetterly S.M., et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 155 (2008) 772-779
76. Penning-van Beest F.J., van der Bij S., Erkens J.A., et al. Effect of non-persistent use of oral glucose-lowering drugs on HbA1c goal attainment. Curr Med Res Opin. 24 (2008) 2523-2529
77. National Council on Patient Information and Education (NCPIE). Enhancing prescription medication adherence: A national action plan, August 2007. http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf Accessed November 20, 2007
78. Bond W.S., and Hussar D.A. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 48 (1991) 1978-1988
79. Rand C.S. Non-adherence with asthma therapy: More than just forgetting. J Pediatr. 146 (2005) 157-159
80. van Dulmen S., Sluijs E., van Dijk L., et al., International Expert Forum on Patient Adherence. Furthering patient adherence: A position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res. 8 (2008) 47
81. Aikens J.E., and Piette J.D. Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care 32 (2009) 19-24
82. Karter A.J., Parker M.M., Moffet H.H., et al. New prescription medication gaps: A comprehensive measure of adherence to new prescriptions. Health Serv Res. 44 (2009) 1640-1661
83. Miller N.H., Hill M., Kottke T., and Ockene I.S. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals. Circulation 95 (1997) 1085-1090
84. Partridge A.H., Wang P.S., Winer E.P., and Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 21 (2003) 602-606
85. Bangsberg D.R. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the future. AIDS Behav. 10 (2006) 249-251
86. Mitchell A.J. High medication discontinuation rates in psychiatry: How often is it understandable?. J Clin Psychopharmacol. 26 (2006) 109-112
87. Ho P.M., Magid D.J., Shetterly S.M., et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 168 (2008) 271-276
88. Mann D.M., Ponieman D., Leventhal H., and Halm E.A. Predictors of adherence to diabetes medications: The role of disease and medication beliefs. J Behav Med 32 (2009) 278-284
89. Bender B.G., Long A., Parasuraman B., and Tran Z.V. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 98 (2007) 322-328
90. Bender B.G., Pedan A., and Varasteh L.T. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 118 (2006) 899-904
91. Haupt D., Krigsman K., and Nilsson J.L. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 30 (2008) 509-514
92. George M., Freedman T.G., Norfleet A.L., et al. Qualitative researchenhanced understanding of patients' beliefs: Results of focus groups with low-income, urban, African American adults with asthma. J Allergy Clin Immunol 111 (2003) 967-973
93. Ulrik C.S., Backer V., Søes-Petersen U., et al. The patient's perspective: Adherence or non-adherence to asthma controller therapy?. J Asthma 43 (2006) 701-704
94. Bender B.G., and Bender S.E. Patientidentified barriers to asthma treatment adherence: Responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 25 (2005) 107-130
95. Schafheutle E.I. The impact of prescription charges on asthma patients is uneven and unpredictable: Evidence from qualitative interviews. http://www.thepcrj.org/journ/aop/pcrj-2008-05-0051.pdf Accessed October 28, 2009
96. Edwards P., Roberts I., Clarke M., et al. Increasing response rates to postal questionnaires: Systematic review. BMJ 324 (2002) 1183
97. Krousel-Wood M., Thomas S., Muntner P., and Morisky D. Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19 (2004) 357-362
98. Lee W.C., Balu S., Cobden D., et al. Prevalence and economic consequences of medication adherence in diabetes: A systematic literature review. Manag Care Interface 19 (2006) 31-41
99. Kaiser H.B. Compliance and non-compliance in asthma. Allergy Asthma Proc 28 (2007) 514-516
100. Seeman E., Compston J., Adachi J., et al. Non-compliance: The Achilles' heel of anti-fracture efficacy. Osteoporos Int 18 (2007) 711-719
101. Liberopoulos E.N., Florentin M., Mikhailidis D.P., and Elisaf M.S. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf 7 (2008) 717-725
102. Centers for Disease Control and Prevention (CDC). Hospital utilization (in non-federal short-stay hospitals). http://www.cdc.gov/nchs/FASTATS/hospital.htm Accessed September 25, 2009
103. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 288 (2002) 455-461
104. Kothawala P., Badamgarav E., Ryu S., et al. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82 (2007) 1493-1501
105. Jones J.K., Gorkin L., Lian J.F., et al. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: A study of a United Kingdom population. BMJ 311 (1995) 293-295
106. Perreault S., Blais L., Lamarre D., et al. Persistence and determinants of statin therapy among middleaged patients for primary and secondary prevention. Br J Clin Pharmacol 59 (2005) 564-573
107. Perreault S., Lamarre D., Blais L., et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 39 (2005) 1401-1408
108. Rossini M., Bianchi G., Di Munno O., et al., Treatment of Osteoporosis in clinical Practice (TOP) Study Group. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17 (2006) 914-921
109. Berg K.M., and Arnsten J.H. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 43 Suppl 1 (2006) S79-S87
110. Hawkshead J., and Krousel-Wood M. Techniques for measuring medication adherence in hypertensive patients in outpatient settings. Dis Manage Health Outcomes 15 (2007) 109-118
111. IMS Health: National Sales Perspectives, Sales Dollars, 2001 & 2008. Plymouth Meeting (2009), IMS Health, Pa
112. IMS Health: National Prescription Audit, Monthly, Total Prescriptions, 2008. Plymouth Meeting (2009), IMS Health, Pa
113. Mushlin A.I., and Appel F.A. Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Arch Intern Med 137 (1977) 318-321
114. Gilbert J.R., Evans C.E., Haynes R.B., and Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J 123 (1980) 119-122
115. Zeller A., Taegtmeyer A., Martina B., et al. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care. Hypertens Res 31 (2008) 1765-1771
116. Turner B.J., and Hecht F.M. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 134 (2001) 1004-1006
117. Miller L.G., Liu H., Hays R.D., et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?. J Gen Intern Med 17 (2002) 1-11
118. Cook C.L., Wade W.E., Martin B.C., and Perri III M. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc (2003) 45 (2005) 151-159
119. Deschamps A.E., De Geest S., Vandamme A.M., et al. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS 22 (2008) 735-743
120. Krishnan J.A., Riekert K.A., McCoy J.V., et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 170 (2004) 1281-1285
121. Liu H., Miller L.G., Hays R.D., et al. A practical method to calibrate selfreported adherence to antiretroviral therapy [published correction appears in J Acquir Immune Defic Syndr. 2007;45:129]. J Acquir Immune Defic Syndr 43 Suppl 1 (2006) S104-S112
122. Santa Helena E.T., Nemes M.I., and Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines [in Portuguese]. Rev Saude Publica 42 (2008) 764-767
123. Godin G., Gagné C., and Naccache H. Validation of a self-reported questionnaire assessing adherence to antiretroviral medication. AIDS Patient Care STDS 17 (2003) 325-332
124. Hansen R.A., Kim M.M., Song L., et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 43 (2009) 413-422
125. Byerly M.J., Nakonezny P.A., and Rush A.J. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 100 (2008) 60-69
126. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986) 67-74
127. Morisky D.E., Ang A., Krousel-Wood M., and Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10 (2008) 348-354
128. Prado Jr. J.C., Kupek E., and Mion Jr. D. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens 21 (2007) 579-584
129. Wu J.R., Moser D.K., De Jong M.J., et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 157 (2009) 285-291
130. Geers H.C., de Blaey C.J., Egberts A.C., et al. Early identification of long-term poor adherence in ambulatory patients. Ann Pharmacother 40 (2006) 2277-2278
131. Karve S., Cleves M.A., Helm M., et al. Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25 (2009) 2303-2310